Skip to main content
SpringerLink
Log in

Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

The liver is the most common site of hematogenous metastases from colorectal carcinoma. Kupffer cells (KC), which line the hepatic sinusoids, may form the first line of defense against circulating tumor cells. The purpose of this study was to determine the effect of hepatic metastases and intro-abdominal tumor growth on KC binding of human colorectal carcinoma (HCRC) cells. MIP-101, a poorly metastatic cell line, and CX-1, a highly metastatic cell line, were injected intrasplenically into nude mice and KC were isolated by collagenase perfusion at varying intervals after injection. Conditioned media were collected from MIP-101, CCL 188 and CX-1 to determine their in vitro effect on KC function. KC from MIP-101 injected mice (14% liver metastases, 100% splenic tumors) bound a significantly greater number of MIP-101 and clone A cells than CX-1 cells in vitro. KC isolated from mice 5 weeks after CX-1 injection (100% liver metastases) also showed increased binding of MIP-101 and clone A cells compared to CX-1 cells. Similar results were obtained when tumor cell binding to normal human liver KC was compared to binding to KC from human livers from patients with hepatic metastasis from colorectal cancer. In contrast KC obtained from mice 3 weeks after CX-1 injection (44% liver metastases) showed significantly decreased binding of MIP-101 and clone A cells. The conditioned medium from CX-1 cells significantly decreased the in vitro binding of both MIP-101 and CX-1 by KC. These results indicate that the ability of KC to bind HCRC cells (which precedes phagocytosis and tumor cell killing) is a dynamic function and affected by concomitant tumor growth. HCRC cells may alter KC function via the production of specific tumor-derived soluble factors. In order to devise new and more effective therapeutic options in the treatment of liver metastases the nature of this tumor cell-KC interaction must be better understood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cohen AM, Shank B and Friedman MA. Colorectal cancer. In: DeVita VT, Hellman S and Rosenberg S, eds. Cancer: principles and practice of oncology, p. 907. Pennsylvania: J.B. Lippincott Company, 1989.

    Google Scholar 

  2. Silverberg E and Lubera J, 1989, Cancer statistics. Cancer, 37, 2–19.

    Google Scholar 

  3. Liotta L and Stetler-Stevenson WG, 1991, Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Research, (Suppl) 51, 50545s–505549s.

    Google Scholar 

  4. Phillips NC, 1989, Kupffer cells and liver metastases. Cancer Metastases Reviews, 8, 231–252.

    Google Scholar 

  5. Pearson HJ, Anderson J, Chamberlain J and Bell PRF, 1986, The effect of Kupffer cell stimulation or depression on the development of liver metastases in the rat. Cancer Immunology and Immunotherapy, 23, 214–216.

    Google Scholar 

  6. Thombre PS and Deodhar S, 1984, Inhibition of liver metastases in murine colon adenocarcinoma by liposomes containing human c-reactive protein or crude lymphokine. Cancer Immunology and Immunotherapy, 16, 145–150.

    Google Scholar 

  7. Nelson DS and Nelson M, 1987, Evasion of host defenses by tumor. Immunology and Cell Biology, 65, 287–304.

    Google Scholar 

  8. Tsunavaki SM, Sporn M, Ding A and Nathan C, 1988, Deactivation of macrophages by transforming growth factor β. Nature, 334, 260–262.

    Google Scholar 

  9. Parhar RS and Lala PK, 1988, Prostaglandin E2 mediated inactivation of various killer lineage cells by tumor bearing host macrophages. Journal of Leucocyte Biology, 44, 474.

    Google Scholar 

  10. Lopez DM, Lopez-Ceparo M, Watson GA, Ganju A, Sotomayor E and Fu Y-X, 1991, Modulation of the immune system by mammary tumor-derived factors. Cancer Investigations, 9, 641–653.

    Google Scholar 

  11. Niles R, Wilhelm S, Steele G, Burke B, Christensen T, Dexter D, O'Brien MS, Thomas P and Zamcheck N, 1987, Isolation and characterization of an undifferentiated human colon carcinoma cell line (MIP101). Cancer Investigation, 5, 545–552.

    Google Scholar 

  12. 12. Wagner HE, Toth CA, Steele GD and Thomas P, 1992, Metastatic potential of human colon cancer cell lines: relationship to cellular differentiation and carcinoembryonic antigen production. Clinical and Experimental Metastasis, 10, 25–31.

    Google Scholar 

  13. Giavazzi R, Jessup J, Campbell D, Walker S and Fidler I, 1986, Experimental nude mouse model of human colorectal cancer liver metastases. Journal of the National Cancer Institute, 77, 1303–1308.

    Google Scholar 

  14. Toth CA, Thomas P, Broitman SA and Zamcheck N, 1985, Receptor mediated endocytosis of carcinoembryonic antigen by rat liver Kupffer cells. Cancer Research, 45, 392–397.

    Google Scholar 

  15. Reske SN, Nyska K and Feinendegen LE, 1981, In-vivo assessment of phagocytic properties of Kupffer cells. Journal of Nuclear Medicine, 22, 405–410.

    Google Scholar 

  16. Frenzel H, Kremer B and Hacher H. The liver sinusoids under various pathological conditions: a TEM and SEM study of rat liver after respiratory hypoxia, telecobalt irradiation and endotoxin application. In: Wisse E and Knook DL, eds. Kupffer Cells and Other Liver Sinusoidal Cells, pp. 213–222. Amsterdam: Elsevier, North Holland Biomedical Press, 1987.

    Google Scholar 

  17. Roerdink FH, Wisse E, Movelt H, Van der Meulen J and Scherphof GL. Cellular distribution of intravenously injected protein containing liposomes in the rat liver. In: Wisse E and Knook DL, eds. Kupffer Cells and Other Liver Sinusoidal Cells, pp. 262–272. Amsterdam: Elsevier, North Holland Biomedical Press, 1977.

    Google Scholar 

  18. Gardner CR, Wasserman AJ and Laskin DL, 1987, Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Research, 47, 6686–6691.

    Google Scholar 

  19. Gjoen T, Seljelid R and Kolset SO, 1989, Binding of metastatic colon carcinoma cells to liver macrophages. Journal of Leucocyte Biology, 45, 362–369.

    Google Scholar 

  20. Williams DL, Sherwood ER, McNamee RB, Jones EL and Diluzio NR, 1985, Therapeutic efficacy of glucan in a murine model of hepatic metastatic disease. Hepatology, 5, 198–206.

    Google Scholar 

  21. Thombre PS and Deodhar SD, 1984, Inhibition of liver metastases in murine colon adenocarcinoma by liposomes containing c-reactive protein or crude lymphokine. Cancer Immunology and Immunotherapy, 16, 145–150.

    Google Scholar 

  22. Brodt P, Blore J, Phillips NC, Meinger JS and Rioux JD, 1981, Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptide. Cancer Immunology and Immunotherapy, 28, 54–58.

    Google Scholar 

  23. Kopper L, Van Hank T and Lapes K, 1982, Experimental model for liver metastasis using Lewis lung tumor. Journal of Cancer Research and Clinical Oncology, 103, 31–38.

    Google Scholar 

  24. Chattopadhyay U, Bhattacharrya S and Chaktabarty NG, 1986, Tumor-associated macrophage mediated lysis of autologous tumor cells. Neoplasma, 33, 157–165.

    Google Scholar 

  25. Duffie GP and Young RI, 1991, Tumoricidal activity of alveolar and peritoneal macrophages of C57BL/6 mice bearing metastatic or nonmetastatic variants of Lewis lung carcinoma. Journal of Leucocyte Biology, 49, 8–14.

    Google Scholar 

  26. Taffet SM and Russell SW, 1981, Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E. Journal of Immunology, 126, 424–427.

    Google Scholar 

  27. Pelus LM and Bockman RS, 1979, Increased prostaglandin synthesis by macrophages from tumor-bearing mice. Journal of Immunology, 123, 2118.

    Google Scholar 

  28. Utsugi T and Fidler IJ, 1991, Prostaglandin E2 does not inhibit tumoricidal activity of mouse macrophages against adherent tumor cells. Journal of Immunology, 146, 2066–2071.

    Google Scholar 

  29. Sotomayor E, Fu X-Y, Lopez-Ceparo M, Herbert L, Jimenez JJ, Albaracin C and Lopez DM, 1991, Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma: 11 Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte macrophage colony stimulating factor. Journal of Immunology, 8, 2816–2823.

    Google Scholar 

  30. Evans R, Kamdar SJ and Duffy TM, 1991, Tumor-derived products induce Il-1a, Il-1b, TNFa and IL 6 gene expression in murine macrophages: distinctions between tumor and bacterial endotoxin induced gene expression. Journal of Leucocyte Biology, 49, 474–482.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Cancer Biology, Department of Surgery, New England Deaconess Hospital, Harvard Medical School, Boston, MA, USA

    Sarkis Meterissian, Glenn D. Steele Jr & Peter Thomas

Authors
  1. Sarkis Meterissian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Glenn D. Steele Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meterissian, S., Steele, G.D. & Thomas, P. Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits. Clin Exp Metast 11, 175–182 (1993). https://doi.org/10.1007/BF00114975

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00114975

Keywords

Search

Navigation